T. Ma
发表
Qifeng Yang,
B. Haffty,
M. Moran,
2011,
PloS one.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2019,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2020,
Clinical breast cancer.
Xiaoyan Li,
Qifeng Yang,
Yi Duan,
2020,
Oncology letters.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Oncogene.
Juan Li,
Na Zhou,
T. Ma,
2017,
PloS one.
Zuping Zhang,
Chenfu Shen,
T. Ma,
2017,
Journal of Neuro-Oncology.
Qifeng Yang,
Xiangnan Kong,
Liyu Jiang,
2016,
Oncology letters.
Qifeng Yang,
B. Haffty,
M. Moran,
2011,
Anticancer research.
Qifeng Yang,
Yalun Li,
Yiran Liang,
2020,
Frontiers in Oncology.
Juan Li,
T. Ma,
Yichan Zhang,
2019,
Clinical lymphoma, myeloma & leukemia.
X. Chen,
Xiaoyan Li,
Qifeng Yang,
2012,
PloS one.
F. Liang,
Ning Zhang,
Xiaoyan Li,
2011,
BMC Medical Genetics.
Qifeng Yang,
Yiran Liang,
Lijuan Wang,
2022,
bioRxiv.
X. Chen,
Xiaolong Wang,
Ning Zhang,
2013,
Gene.
Xiaoyan Li,
Qifeng Yang,
Q. Huo,
2016,
Oncology letters.
Qifeng Yang,
L. Du,
Chuanxin Wang,
2020,
Molecular therapy. Nucleic acids.
Juan Li,
B. Cao,
T. Ma,
2020,
Life sciences.
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Cellular signalling.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Molecular Cancer.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Molecular therapy. Nucleic acids.
Z. Ye,
Y. Liu,
Yuwei Zhang,
2020,
Annals of translational medicine.
Xiaoyan Li,
Qifeng Yang,
Yiran Liang,
2021,
Frontiers in surgery.
Qifeng Yang,
Ning Zhang,
Chang Cai,
2015,
Annals of Surgical Oncology.
Rong Li,
Liang Zhang,
T. Ma,
2019,
Cellular and molecular biology.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2017,
Oncotarget.
Xiaoyan Li,
Qifeng Yang,
Yiran Liang,
2021,
BMC Surgery.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2020,
Molecular Cancer.
Xiaoyan Li,
Qifeng Yang,
Wenjing Zhao,
2019,
Surgical oncology.
Jun-hao Chen,
Juan Li,
T. Ma,
2018,
International Journal of Hematology.
Z. Ye,
Yuwei Zhang,
Hui Li,
2020,
Academic radiology.
A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
X. Chen,
Xiaolong Wang,
Ning Zhang,
2014,
Gene.
Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2022,
Molecular cancer.
Xiaolong Wang,
Qifeng Yang,
Ning Zhang,
2013,
PloS one.
Xiaoyan Li,
Qifeng Yang,
Xiangnan Kong,
2014,
Cellular Physiology and Biochemistry.
Xiaoyan Li,
Qifeng Yang,
Xiaoli Kong,
2019,
The breast journal.
A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
X. Chen,
Xiaolong Wang,
Ning Zhang,
2014,
Gene.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Oncogene.
Qifeng Yang,
Yiran Liang,
Lijuan Wang,
2023,
Cell death & disease.
M. Wang,
T. Ma,
Jie Ding,
2017
.
Xiaoyan Li,
Qifeng Yang,
Ning Zhang,
2019,
Molecular therapy. Nucleic acids.